A carregar...
Varenicline in the treatment of tobacco dependence
Varenicline, a partial agonist of α(4)β(2) nicotinic acetylcholine receptors, is the most recently approved drug for smoking cessation. This paper reviews the outcomes of Phase 2 and Phase 3 clinical trials that assess the efficacy of varenicline in comparison to placebo and other smoking cessation...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2518383/ https://ncbi.nlm.nih.gov/pubmed/18728741 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|